| Predicate |
Object |
| contentType |
Journal Article |
| endingPage |
26 |
| issn |
1573-9546
1573-9538 |
| issueIdentifier |
Suppl 1 |
| pageRange |
3-26 |
| publicationName |
Purinergic Signalling |
| startingPage |
3 |
| bibliographicCitation |
Ford AP. In pursuit of P2X3 antagonists: novel therapeutics for chronic pain and afferent sensitization. Purinergic Signalling. 2011 Nov 18;8(Suppl 1):3–26. doi: 10.1007/s11302-011-9271-6. |
| creator |
http://rdf.ncbi.nlm.nih.gov/pubchem/author/MD5_10fe84557d3660131fd4ffaab0d3c973 |
| date |
2011-11-18-04:00^^<http://www.w3.org/2001/XMLSchema#date> |
| identifier |
https://pubmed.ncbi.nlm.nih.gov/PMC3265711
https://doi.org/10.1007/s11302-011-9271-6
https://pubmed.ncbi.nlm.nih.gov/22095157 |
| isPartOf |
http://rdf.ncbi.nlm.nih.gov/pubchem/journal/32468
https://portal.issn.org/resource/ISSN/1573-9546
https://portal.issn.org/resource/ISSN/1573-9538 |
| language |
English |
| source |
https://pubmed.ncbi.nlm.nih.gov/
https://www.crossref.org/
https://scigraph.springernature.com/ |
| title |
In pursuit of P2X3 antagonists: novel therapeutics for chronic pain and afferent sensitization |
| discussesAsDerivedByTextMining |
http://rdf.ncbi.nlm.nih.gov/pubchem/disease/DZID8756
http://rdf.ncbi.nlm.nih.gov/pubchem/gene/MD5_3310f243507cb1744ab3833b4c862957
http://rdf.ncbi.nlm.nih.gov/pubchem/disease/DZID8494
http://rdf.ncbi.nlm.nih.gov/pubchem/disease/DZID6600
http://rdf.ncbi.nlm.nih.gov/pubchem/disease/DZID11338
http://rdf.ncbi.nlm.nih.gov/pubchem/disease/DZID11328
http://rdf.ncbi.nlm.nih.gov/pubchem/disease/DZID8641
http://rdf.ncbi.nlm.nih.gov/pubchem/disease/DZID8173
http://rdf.ncbi.nlm.nih.gov/pubchem/disease/DZID8995
http://rdf.ncbi.nlm.nih.gov/pubchem/compound/CID5957 |